CClinicalTrials.gg
CompletedNCT05514145Updated Aug 24, 2022

The Effectiveness of Combined Design Nance/Transpalatal Arch Appliance in Maintaining Arch Dimensions After Premature Extraction of Primary Molars

An interventional study of Nance/Transpalatal arch space maintainer and Nance space maintainer in Space Maintenance, sponsored by Alexandria University. Completed at 1 site in Egypt. Open to participants aged 8 Years to 9 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-08-24.

Sponsored by Alexandria University · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 1 year 7 months after the study started (first participant enrolled Jan 2021, registered Aug 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
8 Years to 9 Years
Sex
All
01

Study summary

This study will evaluate the effectiveness of N-TPA appliance compared to Nance SM in maintaining the arch dimensions after bilateral premature extraction of primary molars in children.

Read the detailed description

In this randomized controlled clinical trial, 30 healthy children, 8-9 years of age with premature extraction of bilateral maxillary primary molars will be selected. Children will be randomly allocated into two equal groups of 15 children each according to the type of the appliance that will be used. Group I will receive a a Nance SM, and Group II a combined N-TPA appliance . Panoramic X-rays and study casts will be made, and baseline measurements will be recorded including arch circumference, intermolar width and arch depth. The appliances will be fabricated and cemented intra-orally.

The patients will be followed up at 3, 6 and 9 months for re-evaluation of arch circumference, intermolar width, arch depth, and patient acceptance.

02

Conditions studied

  • Space Maintenance

Keywords

  • Nance/transpalatal arch
  • Nance space maintainer
  • Space maintainer
  • Space maintenance
03

In context

Lead sponsor

Alexandria University is the lead sponsor of 569 studies on the registry; 125 are open to participants now.

Of its 12 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
8 Years to 9 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Fully erupted maxillary permanent first molars.
  • Angle's class I occlusion.(31)
  • Adequate space for premolar eruption according to Moyer's arch length analysis.(31)
  • Fair to good oral hygiene according to Silness and Loe plaque index.(32)
  • No history of allergy to polymethyl methacrylate.

Exclusion criteria

Exclusion Criteria:

  • Children with congenitally absent permanent successors.
  • Children with successors not covered by bone with 2/3 of the root formed.(33)
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
30 participants (actual)

Study arms

  • Active comparator
    Nance space maintainer

    Conventional space maintainer for the maxillary arch as control

    Device: Nance space maintainer

  • Experimental
    Nance/Transpalatal arch space maintainer

    New design of a space maintainer for the maxillary arch

    Device: Nance/Transpalatal arch space maintainer

Interventions

  • DeviceNance/Transpalatal arch space maintainer

    A combined design of both Nance and Transpalatal arch space maintainers as a space maintainer for the maxillary arch in mixed dentition

  • DeviceNance space maintainer

    Conventional space maintainer for the maxillary arch used in mixed dentition

06

What researchers measure

Primary outcomes

  1. Efficacy in maintaining arch dimensions

    All arch dimensions are measured with a 0.5 mm stainless steel wire on the study casts which was then measured with a digital caliper in millimeters (accuracy up to 0.02mm): * Changes in arch circumference after insertion of both Nance and Nance/transpalatal arch (N-TPA) appliances after 3, 6- and 9-months follow-up. * Changes in intermolar width after insertion of both Nance and Nance/transpalatal arch (N-TPA) appliances after 3, 6- and 9-months follow-up. * Changes in arch depth after insertion of both Nance and Nance/transpalatal arch (N-TPA) appliances after 3, 6- and 9-months follow-up.

    Time frame: 9 months

Secondary outcomes

  1. Patient acceptance by modified faces pain scale

    Patient acceptance are measured by the modified faces pain scale of both Nance and N-TPA appliances after 3, 6- and 9-months follow-up. Patient acceptance is measured as : (a) Satisfied (b) Indifferent (c) Dissatisfied

    Time frame: 9 months

07

Study locations

1 site
  • Faculty of dentistry, Alexandria University
    Alexandria, Egypt
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 24, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05514145
Lead sponsor
Alexandria University
Responsible party
Sara Ahmed Elsayed (MSc student, Alexandria University) — Principal investigator
First posted
Aug 24, 2022
Start date
Jan 1, 2021
Primary completion
May 1, 2022
Completion
May 1, 2022
Last update
Aug 24, 2022

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion